RIPK1 and neoplasm: Similarly, in metastatic head and neck squamous cell carcinoma, downregulation of RIPK1 is possibly mediated by enhanced methylation of the RIPK1 promoter in tumour cells and enhances protumorigenic properties such as cell migration.75